Skip to the content
REVOLUTIONIZING TREATMENT DECISIONS
Follow us on
Home
Solutions
INNOVATIVE TRIAL DESIGN
Inform Strategic Decisions
Benefit-Risk Assessment
Resources
Net Treatment Benefit
Press Releases
Regulatory submissions
Blogs
Case studies
Peer-reviewed papers
About
About One2Treat
One2Treat’s Team
Contact
Careers
Request a demo
Home
Solutions
INNOVATIVE TRIAL DESIGN
Inform Strategic Decisions
Benefit-Risk Assessment
Resources
Net Treatment Benefit
Press Releases
Regulatory submissions
Blogs
Case studies
Peer-reviewed papers
About
About One2Treat
One2Treat’s Team
Contact
Careers
Blogs
The key pharmaceutical trends from 2023 according to industry leaders
Back
Read also
Blogs
Net Treatment Benefit in rare disease trials: Aligning trial design with clinically meaningful outcomes
READ MORE
→
Blogs
A Practical Guide to Patient-Centric Trials Using Net Treatment Benefit
READ MORE
→
Innovative Trial Design
OSE Immunotherapeutics and One2Treat jointly won the Innovation award for Endpoint Design in the 2025 Clinical Trials Arena Excellence Awards
READ MORE
→
Blogs
Reactions to Being “Powered By Purpose” on Clinical Trials Day 2025
READ MORE
→
Want to invest in a more holistic understanding
of net treatment benefit?
Get in touch